1. Home
  2. ABCL vs JFR Comparison

ABCL vs JFR Comparison

Compare ABCL & JFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • JFR
  • Stock Information
  • Founded
  • ABCL 2012
  • JFR 2004
  • Country
  • ABCL Canada
  • JFR United States
  • Employees
  • ABCL N/A
  • JFR N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • JFR Trusts Except Educational Religious and Charitable
  • Sector
  • ABCL Health Care
  • JFR Finance
  • Exchange
  • ABCL Nasdaq
  • JFR Nasdaq
  • Market Cap
  • ABCL 1.1B
  • JFR 1.1B
  • IPO Year
  • ABCL 2020
  • JFR N/A
  • Fundamental
  • Price
  • ABCL $4.39
  • JFR $8.38
  • Analyst Decision
  • ABCL Strong Buy
  • JFR
  • Analyst Count
  • ABCL 5
  • JFR 0
  • Target Price
  • ABCL $8.00
  • JFR N/A
  • AVG Volume (30 Days)
  • ABCL 5.5M
  • JFR 621.7K
  • Earning Date
  • ABCL 08-07-2025
  • JFR 01-01-0001
  • Dividend Yield
  • ABCL N/A
  • JFR 11.31%
  • EPS Growth
  • ABCL N/A
  • JFR N/A
  • EPS
  • ABCL N/A
  • JFR N/A
  • Revenue
  • ABCL $32,875,999.00
  • JFR N/A
  • Revenue This Year
  • ABCL N/A
  • JFR N/A
  • Revenue Next Year
  • ABCL $71.11
  • JFR N/A
  • P/E Ratio
  • ABCL N/A
  • JFR N/A
  • Revenue Growth
  • ABCL N/A
  • JFR N/A
  • 52 Week Low
  • ABCL $1.89
  • JFR $7.61
  • 52 Week High
  • ABCL $5.82
  • JFR $8.82
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 51.44
  • JFR 38.51
  • Support Level
  • ABCL $4.01
  • JFR $8.38
  • Resistance Level
  • ABCL $4.81
  • JFR $8.53
  • Average True Range (ATR)
  • ABCL 0.36
  • JFR 0.04
  • MACD
  • ABCL -0.05
  • JFR -0.02
  • Stochastic Oscillator
  • ABCL 42.59
  • JFR 13.49

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About JFR Nuveen Floating Rate Income Fund

Nuveen Floating Rate Income Fund is a diversified closed-end management investment company. Its investment objective is to achieve a high level of current income, consistent with the preservation of capital. It invests in adjustable-rate U.S. dollar-denominated secured Senior Loans.

Share on Social Networks: